{
    "title": "Pfizer leaves COVID product forecast unchanged, shares fall",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11057721/Pfizer-profit-surges-reaffirms-sales-forecast-COVID-19-products.html",
    "date": "2022-07-28",
    "keywords": [
        "vaccine",
        "forecast",
        "covid",
        "street",
        "covid19",
        "treatment",
        "drug",
        "pfizer",
        "year",
        "analyst",
        "business",
        "booster",
        "erman",
        "july",
        "thursday",
        "drugmaker",
        "growth",
        "wall",
        "surge",
        "president",
        "joe",
        "biden",
        "course",
        "bout",
        "company",
        "impact",
        "dollar",
        "rise",
        "biontech",
        "durability",
        "paxlovid",
        "urgency",
        "chris",
        "schott",
        "research",
        "note",
        "sustainability",
        "debate",
        "companys",
        "ability",
        "pipeline",
        "version",
        "fall",
        "demand",
        "month",
        "deal",
        "government",
        "supply",
        "clearance",
        "quarter",
        "picture",
        "breast",
        "cancer",
        "ibrance",
        "arthritis",
        "xeljanz",
        "profit",
        "share",
        "reporting",
        "bengaluru",
        "editing",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}